.webp)
Auto-injectors Market size is poised to reach USD 33 Billion by the end of 2036, growing at a CAGR of 17% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of auto-injectors was USD 10 Billion. The reason behind the growth is impelled by the rising cases of rheumatoid arthritis. Hand disabilities can make it more difficult for individuals with rheumatoid arthritis (RA) to use syringes to give medication as part of their therapy therefore, auto-injectors could potentially mitigate this problem as by using them patients can administer etanercept a medicine used to treat rheumatoid arthritis on their own, in the comfort of their own homes, using an auto-injection pen-like device. Globally, more than 17 million cases of rheumatoid arthritis were reported in 2020.
The growing government initiatives to increase awareness are believed to fuel the market growth. For instance, on June 2023 the Medicines and Healthcare Products Regulatory Agency (MHRA), in collaboration with allergy awareness advocates, released new guidelines outlining the most recent safety recommendations for what to do in the event of anaphylaxis and offered guidance on how to use adrenaline auto-injectors.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~17% |
|
Base Year Market Size (2023) |
~ USD 10 Billion |
|
Forecast Year Market Size (2036) |
~ USD 33 Billion |
|
Regional Scope |
|
Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis)
The anaphylaxis segment in the auto-injectors market is estimated to gain a robust revenue share of 35% in the coming years owing to the rising number of people with food allergies. Globally, food allergies are becoming more common owing to various causes, including, obesity, vitamin D, exposure to ambient chemicals, gut microbiota makeup, cleanliness and lack of exposure to microbiological factors, and environmental chemical exposure. Moreover, experts believe that the number of people with food allergies is expanding, as foods that are generally considered nutritious can be poisonous to someone with allergies.
For certain people, a food allergy can cause anaphylaxis, a severe allergic reaction that happens when the immune system misinterprets a meal or substance as hazardous. This reaction can happen minutes after exposure. Additionally, anaphylaxis is a serious allergic reaction that can be fatal and, if treated right away, may usually be controlled. All these factors are expected to drive the demand for auto-injectors as they are recognized as emergency anaphylaxis therapy. For instance, more than 10 million Americans suffered from food allergies as of 2021.
Product Type (Disposable, Reusable)
Auto-injectors market from the disposable segment is set to garner a notable share. Disposable auto-injectors for prefilled syringes are simple to use and meant for patients to administer fixed-dose injections subcutaneously. Moreover, more than 60% of single-use auto-injectors are disposable and the market is expected to grow owing to the increasing adoption of innovative technologies.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Disease Indication |
|
|
End-Use |
|
|
Technology |
|
|
Route of Administration |
|
North American Market Forecast
Auto-injectors market in North America is predicted to account for the largest share of 45% by 2036 impelled by the rising investment in the healthcare sector. In 2021, healthcare spending made up more than 18% of the country's GDP. The region's advanced healthcare infrastructure encourages more people with a variety of medical problems to use auto-injectors. Recent developments and competitive strategies such as market expansion, mergers and acquisitions, and product launches have been considered to depict a competitive landscape in the market. For instance, in 2023, Coherus BioSciences, Inc. a leading global biosimilar company announced that UDENYCA, a single-dose prefilled auto-injector package, is available for commercial sale which is given the day following chemotherapy to reduce the risk of infection.
APAC Market Statistics
The APAC Auto-injectors market is estimated to be the second largest, during the forecast timeframe led by rising advancement in medical technologies. The 'Make in India' campaign of the Indian government promotes the production of medical devices in the country which has given rise to several advancements and will therefore cause the demand for more sophisticated auto-injectors to skyrocket in the upcoming years that are significant class of medical devices that are self-injectable and capable of delivering medications intramuscularly or subcutaneously.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?